SHILPAMED

What Shilpa Medicare promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 35 tracked 6 delivered 6 missed 23 open
  • Nor-UDCA Formulation Launch delivered, diluted said Q4 FY25 Promised: launch is planned in first half of FY '26 Q1 FY27: Management confirmed the product is 'doing good' but was evasive on providing specific sales data. Phase IV clinical study is ongoing.
  • Unicycive Dedicated Block Commissioning went quiet said Q4 FY25 Promised: expected to be completed in first half of FY '26 Q1 FY27: No mention of the block's commissioning.
  • Unicycive Block Exhibit Batches delayed said Q3 FY26 Promised: exhibit batches will be taken in Q1 FY '27 Q1 FY27: No specific mention of exhibit batches, but the overall program is now expected to be commercialized in FY28, implying a delay.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 35 tracked commitments for Shilpa Medicare — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens